Pharmacological dissociation of novelty responses in the human brain

Cerebral Cortex

Volumn 24, Issue 5, 2014, Pages 1351-1360

  Bunzeck, Nico ^a   Guitart Masip, Marc ^b,c   Dolan, Raymond J ^c   Duzel, Emrah ^b,d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

acetylcholine; dopamine; functional magnetic resonance imaging; novelty; repetition suppression

Indexed keywords

GALANTAMINE; LEVODOPA; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CHOLINERGIC STIMULATION; DISSOCIATION; DOPAMINERGIC TRANSMISSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; LIMBIC SYSTEM; MALE; MEMORY CONSOLIDATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RECOGNITION; SUBSTANTIA NIGRA; TASK PERFORMANCE; VENTRAL TEGMENTUM; ATTENTION; BODY WEIGHT; BRAIN; BRAIN MAPPING; DEFENSE MECHANISM; DRUG EFFECTS; EXPLORATORY BEHAVIOR; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSTIMULATION; REACTION TIME; VASCULARIZATION; YOUNG ADULT;

ATTENTION; BODY WEIGHT; BRAIN; BRAIN MAPPING; CHOLINESTERASE INHIBITORS; DOPAMINE AGENTS; EXPLORATORY BEHAVIOR; FEMALE; GALANTAMINE; HEALTHY VOLUNTEERS; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; PHOTIC STIMULATION; REACTION TIME; RECOGNITION (PSYCHOLOGY); REPRESSION, PSYCHOLOGY; YOUNG ADULT;

EID: 84898925244     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs420     Document Type: Article

References (86)

1. Ashburner J, Friston KJ. 1999. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 7:254-266.
2. Bartus RT, Dean RL. 2009. Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacology (Berl). 202:15-36.
3. Bates ME, Lemay EP. 2004. The D2 test of attention: construct validity and extensions in scoring techniques. J Int Neuropsychol Soc. 10:392-400.
4. Bentley P, Driver J, Dolan RJ. 2011. Cholinergic modulation of cognition: insights from human pharmacological functional neuroima-ging. Prog Neurobiol. 94:360-388.
5. Bethus I, Tse D, Morris RG. 2010. Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptor-dependent paired associates. J Neurosci. 30:1610-1618.
6. Bozzali M, MacPherson SE, Dolan RJ, Shallice T. 2006. Left prefrontal cortex control of novel occurrences during recollection: a psycho- pharmacological study using scopolamine and event-related fMRI. Neuroimage. 33:286-295.
7. Brown MW, Aggleton JP. 2001. Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci. 2:51-61.
8. Brown MW, Xiang JZ. 1998. Recognition memory: neuronal substrates of the judgement of prior occurrence. Prog Neurobiol. 55:149-189.
9. Bunzeck N, Doeller CF, Fuentemilla L, Dolan RJ, Duzel E. 2009. Reward motivation accelerates the onset of neural novelty signals in humans to 85 milliseconds. Curr Biol. 19:1294-1300.
10. Bunzeck N, Duzel E. 2006. Absolute coding of stimulus novelty in the human substantia nigra/VTA. Neuron. 51:369-379.
11. Bunzeck N, Guitart-Masip M, Dolan RJ, Duzel E. 2011. Contextual novelty modulates the neural dynamics of reward anticipation. J Neurosci. 31:12816-12822.
12. Bunzeck N, Schütze H, Stallforth S, Kaufmann J, Düzel S, Heinze H-J, Düzel E. 2007. Mesolimbic novelty processing in older adults. Cereb Cortex. 17:2940-2948.
13. Chapman CA, Yeomans JS, Blaha CD, Blackburn JR. 1997. Increased striatal dopamine efflux follows scopolamine administered sys-temically or to the tegmental pedunculopontine nucleus. Neuro-science. 76:177-186.
14. Chowdhury R, Guitart-Masip M, Bunzeck N, Dolan RJ, Düzel E. 2012. Dopamine modulates episodic memory persistence in old age. J Neurosci. 32:14193-14204.
15. Dagher A, Robbins TW. 2009. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron. 61:502-510.
16. Deichmann R, Gottfried JA, Hutton C, Turner R. 2003. Optimized EPI for fMRI studies of the orbitofrontal cortex. Neuroimage. 19:430-441.
17. Di Giovanni G, Shi WX. 2009. Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine teg-mental nucleus. Synapse. 63:673-680.
18. Dolan RJ, Fletcher PC. 1997. Dissociating prefrontal and hippocampal function in episodic memory encoding. Nature. 388:582-585.
19. Donaldson DI, Petersen SE, Buckner RL. 2001. Dissociating memory retrieval processes using fMRI: evidence that priming does not support recognition memory. Neuron. 31:1047-1059.
20. Duzel E, Bunzeck N, Guitart-Masip M, Wittmann B, Schott BH, Tobler PN. 2009. Functional imaging of the human dopaminergic mid-brain. Trends Neurosci. 32:321-328.
21. Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA. 2004. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. 21:229-235.
22. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM. 2007. Ventral teg-mental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci. 30:289-316.
23. Fried I, MacDonald KA, Wilson CL. 1997. Single neuron activity in human hippocampus and amygdala during recognition of faces and objects. Neuron. 18:753-765.
24. Friston KJ, Fletcher P, Josephs O, Holmes A, Rugg MD, Turner R. 1998. Event-related fMRI: characterizing differential responses. Neuroimage. 7:30-40.
25. Furey ML, Pietrini P, Haxby JV. 2000. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science. 290:2315-2319.
26. Futami T, Takakusaki K, Kitai ST. 1995. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci Res. 21:331-342.
27. Gais S, Born J. 2004. Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. Proc Natl Acad Sci USA. 101:2140-2144.
28. Goldman-Rakic P, Muly I, Williams G. 2000. D1 receptors in prefron-tal cells and circuits. Brain Res Rev. 31:295-301.
29. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1-24.
30. Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 30:220-227.
31. Guitart-Masip M, Bunzeck N, Stephan KE, Dolan RJ, Duzel E. 2010. Contextual novelty changes reward representations in the striatum. J Neurosci. 30:1721-1726.
32. Guitart-Masip M, Chowdhury R, Sharot T, Dayan P, Duzel E, Dolan RJ. 2012. Action controls dopaminergic enhancement of reward representations. Proc Natl Acad Sci USA. 109:7511-7516.
33. Hasselmo ME. 1999. Neuromodulation: acetylcholine and memory consolidation. Trends Cogn Sci. 3:351-359.
34. Hasselmo ME. 2006. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 16:710-715.
35. Hasselmo ME, Giocomo LM. 2006. Cholinergic modulation of cortical function. J Mol Neurosci. 30:133-135.
36. Hasselmo ME, McGaughy J. 2004. High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Prog Brain Res. 145:207-231.
37. Hasselmo ME, Sarter M. 2011. Modes and models of forebrain cholin-ergic neuromodulation of cognition. Neuropsychopharmacology. 36:52-73.
38. Heckers S. 2001. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus. 11:520-528.
39. Helms G, Draganski B, Frackowiak R, Ashburner J, Weiskopf N. 2009. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. Neuroimage. 47:194-198.
40. Henson R, Shallice T, Dolan R. 2000. Neuroimaging evidence for dissociable forms of repetition priming. Science. 287:1269-1272.
41. Henson RN, Shallice T, Gorno-Tempini ML, Dolan RJ. 2002. Face repetition effects in implicit and explicit memory tests as measured by fMRI. Cereb Cortex. 12:178-186.
42. Herreras O, Solis JM, Herranz AS, Martin del Rio R, Lerma J. 1988. Sensory modulation of hippocampal transmission. II. Evidence for a cholinergic locus of inhibition in the Schaffer-CA1 synapse. Brain Res. 461:303-313.
43. Hutton C, Bork A, Josephs O, Deichmann R, Ashburner J, Turner R. 2002. Image distortion correction in fMRI: a quantitative evaluation. Neuroimage. 16:217-240.
44. Kapur S. 2003. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 160:13-23.
45. Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Floel A, Zwitserlood P, Ringelstein EB. 2004. Levodopa: faster and better word learning in normal humans. Ann Neurol. 56:20-26.
46. Knight R. 1996. Contribution of human hippocampal region to novelty detection. Nature. 383:256-259.
47. Krebs RM, Heipertz D, Schuetze H, Duzel E. 2011. Novelty increases the mesolimbic functional connectivity of the substantia nigra/ventral tegmental area (SN/VTA) during reward anticipation: evidence from high-resolution fMRI. Neuroimage. 58:647-655.
48. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. 1991. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H] spiperone and [3H]SCH23390. Neuroscience. 40:657-671.
49. Lisman J, Grace AA, Duzel E. 2011. A neoHebbian framework for episodic memory: role of dopamine-dependent late LTP. Trends Neurosci. 34:536-547.
50. Lisman JE, Grace AA. 2005. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 46:703-713.
51. Lisman JE, Otmakhova NA. 2001. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SO-CRATIC model to account for normal and aberrant effects of dopamine. Hippocampus. 11:551-568.
52. Lodge DJ, Grace AA. 2007. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci. 27:11424-11430.
53. Mansvelder H, Van Aerde K, Couey J, Brussaard A. 2006. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology. 184:292-305.
54. Mark GP, Shabani S, Dobbs LK, Hansen ST. 2011. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav. 104:76-81.
55. Mesulam M. 2004. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem. 11:43-49.
56. Mesulam MM. 2004. The cholinergic innervation of the human cerebral cortex. Prog Brain Res. 145:67-78.
57. Mesulam MM. 1998. From sensation to cognition. Brain. 121(Pt 6):1013-1052.
58. Mesulam MM, Mufson EJ, Levey AI, Wainer BH. 1983. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol. 214:170-197.
59. Miller AD, Blaha CD. 2004. Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors. Neuroreport. 15:1805-1808.
60. Miller EK, Desimone R. 1994. Parallel neuronal mechanisms for short-term memory. Science. 263:520-522.
61. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK. 1995. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci. 15:5859-5869.
62. Oh MM, Wu WW, Power JM, Disterhoft JF. 2006. Galantamine increases excitability of CA1 hippocampal pyramidal neurons. Neuroscience. 137:113-123.
63. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. 2006. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature. 442:1042-1045.
64. Ranganath C, Rainer G. 2003. Neural mechanisms for detecting and remembering novel events. Nat Rev Neurosci. 4:193-202.
65. Rogers JL, Kesner RP. 2003. Cholinergic modulation of the hippocampus during encoding and retrieval. Neurobiol Learn Mem. 80:332-342.
66. Rogers JL, Kesner RP. 2004. Cholinergic modulation of the hippocampus during encoding and retrieval of tone/shock-induced fear conditioning. Learn Mem. 11:102-107.
67. Rutishauser U, Mamelak AN, Schuman EM. 2006. Single-trial learning of novel stimuli by individual neurons of the human hippocampus-amygdala complex. Neuron. 49:805-813.
68. Seeman P, Madras BK. 1998. Anti-hyperactivity medication: methyl-phenidate and amphetamine. Mol Psychiatry. 3:386-396.
69. Shohamy D, Adcock RA. 2010. Dopamine and adaptive memory. Trends Cogn Sci. 14:464-472.
70. Sokolov EN. 1963. Higher nervous functions; the orienting reflex. Annu Rev Physiol. 25:545-580.
71. Strange BA, Fletcher PC, Henson RN, Friston KJ, Dolan RJ. 1999. Segregating the functions of human hippocampus. Proc Natl Acad Sci USA. 96:4034-4039.
72. Thiel CM. 2003. Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging. Neu-robiol Learn Mem. 80:234-244.
73. Thiel CM, Huston JP, Schwarting RK. 1998. Hippocampal acetyl-choline and habituation learning. Neuroscience. 85:1253-1262.
74. Thiel CM, Zilles K, Fink GR. 2005. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology. 30:810-820.
75. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ. 2012. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron. 75:58-64.
76. Tulving E. 1985. Memory and consciousness. Can Psychol. 1-12.
77. Tulving E, Markowitsch HJ, Craik FE, Habib R, Houle S. 1996. Novelty and familiarity activations in PET studies of memory encoding and retrieval. Cereb Cortex. 6:71-79.
78. Van Schouwenburg M, Aarts E, Cools R. 2010. Dopaminergic modulation of cognitive control: distinct roles for the prefrontal cortex and the basal ganglia. Curr Pharm Des. 16:2026-2032.
79. Weiskopf N, Hutton C, Josephs O, Deichmann R. 2006. Optimal EPI parameters for reduction of susceptibility-induced BOLD sensitivity losses: a whole-brain analysis at 3 T and 1.5 T. Neuroimage. 33:493-504.
80. Wilson FA, Rolls ET. 1990. Learning and memory is reflected in the responses of reinforcement-related neurons in the primate basal forebrain. J Neurosci. 10:1254-1267.
81. Winson J, Abzug C. 1978. Dependence upon behavior of neuronal transmission from perforant pathway through entorhinal cortex. Brain Res. 147:422-427.
82. Winters BD, Saksida LM, Bussey TJ. 2006. Paradoxical facilitation of object recognition memory after infusion of scopolamine into peri-rhinal cortex: implications for cholinergic system function. J Neurosci. 26:9520-9529.
83. Wittmann BC, Bunzeck N, Dolan RJ, Duzel E. 2007. Anticipation of novelty recruits reward system and hippocampus while promoting recollection. Neuroimage. 38:194-202.
84. Xiang JZ, Brown MW. 1998. Differential neuronal encoding of novelty, familiarity and recency in regions of the anterior temporal lobe. Neuropharmacology. 37:657-676.
85. Yamaguchi S, Hale LA, D'Esposito M, Knight RT. 2004. Rapid prefrontal-hippocampal habituation to novel events. J Neurosci. 24:5356-5363.
86. Zilles K, Palomero-Gallagher N, Schleicher A. 2004. Transmitter receptors and functional anatomy of the cerebral cortex. J Anat. 205:417-432.